<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>04065265824965</udiDi>
    <basicUdiDi>008416831504R-1CX</basicUdiDi>
    <tradeName>P504s (13H4) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>504R-14</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-20T11:10:08.691Z</lastUpdated>
  </row>
  <row>
    <udiDi>04065265824972</udiDi>
    <basicUdiDi>008416831504R-1CX</basicUdiDi>
    <tradeName>P504s (13H4) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>504R-15</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-20T11:10:08.678Z</lastUpdated>
  </row>
  <row>
    <udiDi>04065265824989</udiDi>
    <basicUdiDi>008416831504R-1CX</basicUdiDi>
    <tradeName>P504s (13H4) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>504R-16</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-20T11:10:08.666Z</lastUpdated>
  </row>
  <row>
    <udiDi>04065265824996</udiDi>
    <basicUdiDi>008416831504R-1CX</basicUdiDi>
    <tradeName>P504s (13H4) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>504R-17</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-20T11:10:08.656Z</lastUpdated>
  </row>
  <row>
    <udiDi>04065265825009</udiDi>
    <basicUdiDi>008416831504R-1CX</basicUdiDi>
    <tradeName>P504s (13H4) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>504R-18</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-20T11:10:08.645Z</lastUpdated>
  </row>
  <row>
    <udiDi>04065266055719</udiDi>
    <basicUdiDi>008416831484R-1FA</basicUdiDi>
    <tradeName>PRAME (EP461) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>484R-10</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-20T11:10:08.629Z</lastUpdated>
  </row>
  <row>
    <udiDi>04065266499322</udiDi>
    <basicUdiDi>008416831485A-1CU</basicUdiDi>
    <tradeName>ATRX Rabbit Polyclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>485A-14</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-20T11:10:08.616Z</lastUpdated>
  </row>
  <row>
    <udiDi>04065266499346</udiDi>
    <basicUdiDi>008416831485A-1CU</basicUdiDi>
    <tradeName>ATRX Rabbit Polyclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>485A-15</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-20T11:10:08.604Z</lastUpdated>
  </row>
  <row>
    <udiDi>04065266499353</udiDi>
    <basicUdiDi>008416831485A-1CU</basicUdiDi>
    <tradeName>ATRX Rabbit Polyclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>485A-16</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-20T11:10:08.591Z</lastUpdated>
  </row>
  <row>
    <udiDi>04065266499377</udiDi>
    <basicUdiDi>008416831485A-1CU</basicUdiDi>
    <tradeName>ATRX Rabbit Polyclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>485A-17</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-20T11:10:08.579Z</lastUpdated>
  </row>
  <row>
    <udiDi>04065266499391</udiDi>
    <basicUdiDi>008416831485A-1CU</basicUdiDi>
    <tradeName>ATRX Rabbit Polyclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>485A-18</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-20T11:10:08.565Z</lastUpdated>
  </row>
  <row>
    <udiDi>04065268527283</udiDi>
    <basicUdiDi>008416831760-71712P</basicUdiDi>
    <tradeName>ATRX Rabbit Polyclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>760-7171</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-20T11:10:08.236Z</lastUpdated>
  </row>
  <row>
    <udiDi>04065268527290</udiDi>
    <basicUdiDi>008416831760-71722R</basicUdiDi>
    <tradeName>SF-1 (EP434) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>760-7172</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-20T11:10:08.216Z</lastUpdated>
  </row>
  <row>
    <udiDi>04065268527306</udiDi>
    <basicUdiDi>008416831760-71732T</basicUdiDi>
    <tradeName>IDH1 R132H (MRQ-67) Rabbit Monoclonal Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>760-7173</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-20T11:10:08.191Z</lastUpdated>
  </row>
  <row>
    <udiDi>04065271108967</udiDi>
    <basicUdiDi>008416831760-72262P</basicUdiDi>
    <tradeName>Claudin-4 (EP417) Rabbit Monoclonal Primary Antibody</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cell Marque Corporation</manufacturerName>
    <manufacturerSrn>US-MF-000028332</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>760-7226</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-20T11:10:07.927Z</lastUpdated>
  </row>
</eudamedExport>